Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 410

1.

Performance of multiplex serology in discriminating active vs past Helicobacter pylori infection in a primarily African American population in the southeastern United States.

Butt J, Blot WJ, Shrubsole MJ, Varga MG, Hendrix LH, Crankshaw S, Waterboer T, Pawlita M, Epplein M.

Helicobacter. 2019 Nov 20:e12671. doi: 10.1111/hel.12671. [Epub ahead of print]

PMID:
31746104
2.

The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: a nested case-control study from eight East Asian cohort studies.

Jang J, Wang T, Cai H, Ye F, Murphy G, Shimazu T, Taylor PR, Qiao YL, Yoo KY, Jee SH, Kim J, Chen SC, Abnet CC, Tsugane S, Zheng W, Shu XO, Pawlita M, Park SK, Epplein M.

Int J Cancer. 2019 Nov 19. doi: 10.1002/ijc.32790. [Epub ahead of print]

PMID:
31745972
3.

Circulating antibodies against Epstein-Barr virus (EBV) and p53 in EBV-positive and -negative gastric cancer.

Camargo MC, Kim KM, Matsuo K, Torres J, Liao LM, Morgan D, Michel A, Waterboer T, Song M, Gulley ML, Dominguez RL, Yatabe Y, Kim S, Cortes-Martinez G, Lissowska J, Zabaleta J, Pawlita M, Rabkin CS.

Cancer Epidemiol Biomarkers Prev. 2019 Nov 12. pii: cebp.0790.2019. doi: 10.1158/1055-9965.EPI-19-0790. [Epub ahead of print]

PMID:
31719065
4.

High Ambient Solar UV Correlates with Greater Beta HPV Seropositivity in New South Wales, Australia.

Kricker A, Weber MF, Brenner N, Banks E, Pawlita M, Sitas F, Hodgkinson VS, Rahman B, van Kemenade CH, Armstrong BK, Waterboer T.

Cancer Epidemiol Biomarkers Prev. 2019 Oct 9. doi: 10.1158/1055-9965.EPI-19-0400. [Epub ahead of print]

PMID:
31597664
5.

Antibody Responses to Fusobacterium nucleatum Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer.

Butt J, Jenab M, Pawlita M, Overvad K, Tjonneland A, Olsen A, Boutron-Ruault MC, Carbonnel F, Mancini FR, Kaaks R, Kühn T, Boeing H, Trichopoulou A, Karakatsani A, Palli D, Pala VM, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita B, van Gils CH, Vermeulen RCH, Weiderpass E, Quirós JR, Duell EJ, Sánchez MJ, Dorronsoro M, Huerta JM, Ardanaz E, Van Guelpen B, Harlid S, Perez-Cornago A, Gunter MJ, Murphy N, Freisling H, Aune D, Waterboer T, Hughes DJ.

Cancer Epidemiol Biomarkers Prev. 2019 Sep;28(9):1552-1555. doi: 10.1158/1055-9965.EPI-19-0313.

PMID:
31481495
6.

Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients.

Laban S, Gangkofner DS, Holzinger D, Schroeder L, Eichmüller SB, Zörnig I, Jäger D, Wichmann G, Dietz A, Broglie MA, Herold-Mende CC, Dyckhoff G, Boscolo-Rizzo P, Ezić J, Marienfeld R, Möller P, Kraus JM, Völkel G, Kestler HA, Brunner C, Schuler PJ, Wigand MC, Theodoraki MN, Doescher J, Hoffmann TK, Pawlita M, Waterboer T, Butt J.

Clin Cancer Res. 2019 Aug 23. doi: 10.1158/1078-0432.CCR-19-1490. [Epub ahead of print]

PMID:
31444248
7.

Squamous cell carcinoma of the nasal cavity: A descriptive analysis of cases from the head and neck 5000 study.

Dale OT, Pring M, Davies A, Leary S, Ingarfield K, Toms S, Waterboer T, Pawlita M, Ness AR, Thomas SJ.

Clin Otolaryngol. 2019 Aug 16. doi: 10.1111/coa.13414. [Epub ahead of print]

PMID:
31419373
8.

Absence of disruptive TP53 mutations in high-risk human papillomavirus-driven neck squamous cell carcinoma of unknown primary.

Boscolo-Rizzo P, Schroeder L, Sacchetto V, Holzinger D, Da Mosto MC, Tirelli G, Dal Cin E, Mantovani M, Menegaldo A, Del Mistro A, Romeo S, Dei Tos AP, Niero M, Rigo S, Dyckhoff G, Hess J, Alemany L, Quer M, León X, Polesel J, Pawlita M, Bertorelle R.

Head Neck. 2019 Nov;41(11):3833-3841. doi: 10.1002/hed.25915. Epub 2019 Aug 15.

PMID:
31414564
9.

Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.

Gangkofner DS, Holzinger D, Schroeder L, Eichmüller SB, Zörnig I, Jäger D, Wichmann G, Dietz A, Broglie MA, Herold-Mende C, Dyckhoff G, Boscolo-Rizzo P, Ezic J, Marienfeld RB, Möller P, Völkel G, Kraus JM, Kestler HA, Brunner C, Schuler PJ, Wigand M, Theodoraki MN, Doescher J, Hoffmann TK, Pawlita M, Butt J, Waterboer T, Laban S.

Int J Cancer. 2019 Dec 15;145(12):3436-3444. doi: 10.1002/ijc.32623. Epub 2019 Aug 26.

PMID:
31407331
10.

Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58.

de Sanjosé S, Serrano B, Tous S, Alejo M, Lloveras B, Quirós B, Clavero O, Vidal A, Ferrándiz-Pulido C, Pavón MÁ, Holzinger D, Halec G, Tommasino M, Quint W, Pawlita M, Muñoz N, Bosch FX, Alemany L; RIS HPV TT, VVAP and Head and Neck study groups .

JNCI Cancer Spectr. 2019 Jan 7;2(4):pky045. doi: 10.1093/jncics/pky045. eCollection 2018 Oct.

11.

Antibody responses to flagellin C and Streptococcus gallolyticus pilus proteins in colorectal cancer.

Butt J, Fernández de Larrea N, Tjalsma H, Roelofs R, Kato I, Martín V, Pérez-Gómez B, Moreno V, Dierssen-Sotos T, Castilla J, Fernández-Tardón G, Amiano P, Salas D, Alguacil J, Jiménez-Moleón JJ, Huerta JM, de Sanjosé S, Del Campo R, Kogevinas M, Pollán M, Pawlita M, Waterboer T, Boleij A, Aragonés N.

Sci Rep. 2019 Jul 26;9(1):10847. doi: 10.1038/s41598-019-47347-6.

12.

Smoking, Helicobacter Pylori Serology, and Gastric Cancer Risk in Prospective Studies from China, Japan, and Korea.

Butt J, Varga MG, Wang T, Tsugane S, Shimazu T, Zheng W, Abnet CC, Yoo KY, Park SK, Kim J, Jee SH, Qiao YL, Shu XO, Waterboer T, Pawlita M, Epplein M.

Cancer Prev Res (Phila). 2019 Oct;12(10):667-674. doi: 10.1158/1940-6207.CAPR-19-0238. Epub 2019 Jul 26.

PMID:
31350279
13.

Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana.

Krings A, Dunyo P, Pesic A, Tetteh S, Hansen B, Gedzah I, Wormenor CM, Amuah JE, Behnke AL, Höfler D, Pawlita M, Kaufmann AM.

PLoS One. 2019 Jun 27;14(6):e0218762. doi: 10.1371/journal.pone.0218762. eCollection 2019.

14.

Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium.

Kreimer AR, Ferreiro-Iglesias A, Nygard M, Bender N, Schroeder L, Hildesheim A, Robbins HA, Pawlita M, Langseth H, Schlecht NF, Tinker LF, Agalliu I, Smoller SW, Ness-Jensen E, Hveem K, D'Souza G, Visvanathan K, May B, Ursin G, Weiderpass E, Giles GG, Milne RL, Cai Q, Blot WJ, Zheng W, Weinstein SJ, Albanes D, Brenner N, Hoffman-Bolton J, Kaaks R, Barricarte A, Tjønneland A, Sacerdote C, Trichopoulou A, Vermeulen RCH, Huang WY, Freedman ND, Brennan P, Waterboer T, Johansson M.

Ann Oncol. 2019 Jun 11. pii: mdz138. doi: 10.1093/annonc/mdz138. [Epub ahead of print]

15.

Geospatial analyses identify regional hot spots of diffuse gastric cancer in rural Central America.

Dominguez RL, Cherry CB, Estevez-Ordonez D, Mera R, Escamilla V, Pawlita M, Waterboer T, Wilson KT, Peek RM, Tavera G, Williams SM, Gulley ML, Emch M, Morgan DR.

BMC Cancer. 2019 Jun 7;19(1):545. doi: 10.1186/s12885-019-5726-x.

16.

Soy and tea intake on cervical cancer risk: the Singapore Chinese Health Study.

Paul P, Koh WP, Jin A, Michel A, Waterboer T, Pawlita M, Wang R, Yuan JM, Butler LM.

Cancer Causes Control. 2019 Aug;30(8):847-857. doi: 10.1007/s10552-019-01173-3. Epub 2019 Jun 1.

PMID:
31154549
17.

Epstein Barr virus antibody reactivity and gastric cancer: A population-based case-control study.

Aragonés N, Fernández de Larrea N, Pastor-Barriuso R, Michel A, Romero B, Pawlita M, Mayorgas-Torralba S, Martín V, Moreno V, Casabonne D, Castilla J, Fernandez-Tardón G, Dierssen-Sotos T, Capelo R, Salas D, Salcedo-Bellido I, Chirlaque MD, Brenner N, Pedraza M, Bessa X, Pérez-Gómez B, Butt J, Kogevinas M, Del Campo R, de Sanjosé S, Waterboer T, Pollán M.

Cancer Epidemiol. 2019 Aug;61:79-88. doi: 10.1016/j.canep.2019.05.008. Epub 2019 May 30.

PMID:
31154081
18.

Human Papillomavirus Serologic Profiles of Selected Filipinos with Head and Neck Squamous Cell Carcinoma.

Albano PM, Salvador C, Orosa J, Racelis S, Leaño M, Michel A, Ramos JD, Holzinger D, Pawlita M.

J Pathol Transl Med. 2019 Sep;53(5):273-279. doi: 10.4132/jptm.2019.05.12. Epub 2019 May 30.

19.

Comparison of multiplex-serology and ELISA based methods in detecting HPV16 L1 antibody responses in paired saliva and serum samples of healthy men.

Loimaranta V, Sievi K, Werner J, Pawlita M, Waterboer T, Butt J, Syrjänen S.

J Virol Methods. 2019 Aug;270:26-33. doi: 10.1016/j.jviromet.2019.04.007. Epub 2019 Apr 17.

PMID:
31004663
20.

Post-treatment human papillomavirus antibody kinetics in cervical cancer patients.

Piontek T, Harmel C, Pawlita M, Carow K, Schröter J, Runnebaum IB, Dürst M, Graw F, Waterboer T.

Philos Trans R Soc Lond B Biol Sci. 2019 May 27;374(1773):20180295. doi: 10.1098/rstb.2018.0295.

PMID:
30955486
21.

Mucosal and cutaneous Human Papillomavirus seroprevalence among adults in the prevaccine era in Germany - Results from a nationwide population-based survey.

Loenenbach AD, Poethko-Müller C, Pawlita M, Thamm M, Harder T, Waterboer T, Schröter J, Deleré Y, Wichmann O, Wiese-Posselt M.

Int J Infect Dis. 2019 Jun;83:3-11. doi: 10.1016/j.ijid.2019.03.022. Epub 2019 Mar 20.

22.

Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up.

Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M, Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA, Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M, Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke M.

Geburtshilfe Frauenheilkd. 2019 Feb;79(2):160-176. doi: 10.1055/a-0828-7722. Epub 2019 Feb 18.

23.

Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.

Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M, Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA, Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M, Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke M.

Geburtshilfe Frauenheilkd. 2019 Feb;79(2):148-159. doi: 10.1055/a-0818-5440. Epub 2019 Feb 18.

24.

Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow-up cohort study.

Basu P, Muwonge R, Bhatla N, Nene BM, Joshi S, Esmy PO, Poli URR, Joshi G, Verma Y, Zomawia E, Shastri SS, Pimple S, Anantharaman D, Prabhu PR, Hingmire S, Sauvaget C, Lucas E, Pawlita M, Gheit T, Jayant K, Malvi SG, Siddiqi M, Michel A, Butt J, Sankaran S, Rameshwari Ammal Kannan TP, Varghese R, Divate U, Willhauck-Fleckenstein M, Waterboer T, Müller M, Sehr P, Vashist S, Mishra G, Jadhav R, Thorat R, Tommasino M, Pillai MR, Sankaranarayanan R; Indian HPV vaccine study group.

Papillomavirus Res. 2019 Jun;7:75-81. doi: 10.1016/j.pvr.2019.01.004. Epub 2019 Jan 31.

25.

Validation of monoplex assays detecting antibodies against Corynebacterium diphtheriae and Clostridium tetani toxins, rubella virus and parvovirus B19 for incorporation into Multiplex Serology.

Brenner N, Butt J, Bomfim IL, Tabatabai J, Pawlita M, Schnitzler P, Waterboer T.

Methods. 2019 Apr 1;158:44-53. doi: 10.1016/j.ymeth.2019.01.013. Epub 2019 Jan 28.

PMID:
30703462
26.

Dietary behaviors and survival in people with head and neck cancer: Results from Head and Neck 5000.

Lang S, Schimansky S, Beynon R, Penfold C, Davies A, Waylen A, Thomas S, Pring M, Pawlita M, Waterboer T, Ness AR.

Head Neck. 2019 Jul;41(7):2074-2084. doi: 10.1002/hed.25660. Epub 2019 Jan 30.

PMID:
30698303
27.

Development and validation of HIV-1 Multiplex Serology.

Kranz LM, Gärtner B, Michel A, Pawlita M, Waterboer T, Brenner N.

J Immunol Methods. 2019 Mar;466:47-51. doi: 10.1016/j.jim.2019.01.007. Epub 2019 Jan 18.

PMID:
30660622
28.

Validation of Multiplex Serology for human hepatitis viruses B and C, human T-lymphotropic virus 1 and Toxoplasma gondii.

Brenner N, Mentzer AJ, Butt J, Braband KL, Michel A, Jeffery K, Klenerman P, Gärtner B, Schnitzler P, Hill A, Taylor G, Demontis MA, Guy E, Hadfield SJ, Almond R, Allen N, Pawlita M, Waterboer T.

PLoS One. 2019 Jan 7;14(1):e0210407. doi: 10.1371/journal.pone.0210407. eCollection 2019.

29.

Validation of Multiplex Serology detecting human herpesviruses 1-5.

Brenner N, Mentzer AJ, Butt J, Michel A, Prager K, Brozy J, Weißbrich B, Aiello AE, Meier HCS, Breuer J, Almond R, Allen N, Pawlita M, Waterboer T.

PLoS One. 2018 Dec 27;13(12):e0209379. doi: 10.1371/journal.pone.0209379. eCollection 2018.

30.

Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000.

Schimansky S, Lang S, Beynon R, Penfold C, Davies A, Waylen A, Thomas S, Pring M, Pawlita M, Waterboer T, Ness A.

Head Neck. 2019 Apr;41(4):1053-1062. doi: 10.1002/hed.25543. Epub 2018 Dec 14.

31.

Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin Lymphoma.

Halec G, Waterboer T, Brenner N, Butt J, Hardy WD, DʼSouza G, Wolinsky S, Macatangay BJ, Pawlita M, Detels R, Martínez-Maza O, Hussain SK.

J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):e53-e63. doi: 10.1097/QAI.0000000000001916.

PMID:
30531297
32.

Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.

Butt J, Varga MG, Blot WJ, Teras L, Visvanathan K, Le Marchand L, Haiman C, Chen Y, Bao Y, Sesso HD, Wassertheil-Smoller S, Ho GYF, Tinker LE, Peek RM, Potter JD, Cover TL, Hendrix LH, Huang LC, Hyslop T, Um C, Grodstein F, Song M, Zeleniuch-Jacquotte A, Berndt S, Hildesheim A, Waterboer T, Pawlita M, Epplein M.

Gastroenterology. 2019 Jan;156(1):175-186.e2. doi: 10.1053/j.gastro.2018.09.054. Epub 2018 Oct 6.

PMID:
30296434
33.

DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival.

Ambatipudi S, Langdon R, Richmond RC, Suderman M, Koestler DC, Kelsey KT, Kazmi N, Penfold C, Ho KM, McArdle W, Ring SM, Pring M, Waterboer T, Pawlita M, Gaunt TR, Davey Smith G, Thomas S, Ness AR, Relton CL.

Oral Oncol. 2018 Oct;85:87-94. doi: 10.1016/j.oraloncology.2018.08.021. Epub 2018 Sep 5.

34.

Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer.

Epplein M, Butt J, Zhang Y, Hendrix LH, Abnet CC, Murphy G, Zheng W, Shu XO, Tsugane S, Qiao YL, Taylor PR, Shimazu T, Yoo KY, Park SK, Kim J, Jee SH, Waterboer T, Pawlita M, You WC, Pan KF.

Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1472-1479. doi: 10.1158/1055-9965.EPI-18-0582. Epub 2018 Aug 29.

35.

JC polyomavirus replication and associated disease in pediatric renal transplantation: an international CERTAIN Registry study.

Höcker B, Tabatabai J, Schneble L, Oh J, Thiel F, Pape L, Rusai K, Topaloglu R, Kranz B, Klaus G, Printza N, Yavascan O, Fichtner A, Krupka K, Bruckner T, Waldherr R, Pawlita M, Schnitzler P, Hirsch HH, Tönshoff B.

Pediatr Nephrol. 2018 Dec;33(12):2343-2352. doi: 10.1007/s00467-018-4029-9. Epub 2018 Jul 30.

PMID:
30058047
36.

Cytomegalovirus (CMV) seroprevalence in the adult population of Germany.

Lachmann R, Loenenbach A, Waterboer T, Brenner N, Pawlita M, Michel A, Thamm M, Poethko-Müller C, Wichmann O, Wiese-Posselt M.

PLoS One. 2018 Jul 25;13(7):e0200267. doi: 10.1371/journal.pone.0200267. eCollection 2018.

37.

Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium.

Butt J, Blot WJ, Teras LR, Visvanathan K, Le Marchand L, Haiman CA, Chen Y, Bao Y, Sesso HD, Wassertheil-Smoller S, Ho GY, Tinker LF, Peek RM, Potter JD, Cover TL, Hendrix LH, Huang LC, Waterboer T, Pawlita M, Epplein M.

Cancer Epidemiol Biomarkers Prev. 2018 Oct;27(10):1186-1194. doi: 10.1158/1055-9965.EPI-18-0249. Epub 2018 Jul 23.

38.

Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia.

Varga MG, Cai H, Waterboer T, Murphy G, Shimazu T, Taylor PR, Qiao YL, Park SK, Yoo KY, Jee SH, Cho ER, Kim J, Abnet CC, Tsugane S, Cai Q, Zheng W, Pawlita M, Shu XO, Epplein M.

Dig Dis Sci. 2018 Oct;63(10):2765-2772. doi: 10.1007/s10620-018-5154-9. Epub 2018 Jun 8.

39.

Role of mucosal high-risk human papillomavirus types in head and neck cancers in Romania.

Ursu RG, Danciu M, Spiridon IA, Ridder R, Rehm S, Maffini F, McKay-Chopin S, Carreira C, Lucas E, Costan VV, Popescu E, Cobzeanu B, Ghetu N, Iancu LS, Tommasino M, Pawlita M, Holzinger D, Gheit T.

PLoS One. 2018 Jun 25;13(6):e0199663. doi: 10.1371/journal.pone.0199663. eCollection 2018.

40.

Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal cohort study.

Jansen F, Verdonck-de Leeuw IM, Cuijpers P, Leemans CR, Waterboer T, Pawlita M, Penfold C, Thomas SJ, Waylen A, Ness AR.

Psychooncology. 2018 Sep;27(9):2245-2256. doi: 10.1002/pon.4816. Epub 2018 Jul 23.

41.

Predictors of oropharyngeal cancer survival in Europe.

Anantharaman D, Billot A, Waterboer T, Gheit T, Abedi-Ardekani B, Lagiou P, Lagiou A, Ahrens W, Holcátová I, Merletti F, Kjaerheim K, Polesel J, Simonato L, Alemany L, Mena Cervigon M, Macfarlane TV, Znaor A, Thomson PJ, Robinson M, Canova C, Conway DI, Wright S, Healy CM, Toner ME, Pawlita M, Tommasino M, Brennan P.

Oral Oncol. 2018 Jun;81:89-94. doi: 10.1016/j.oraloncology.2018.04.016. Epub 2018 May 2.

42.

Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial.

Michels J, Becker N, Suciu S, Kaiser I, Benner A, Kosaloglu-Yalcin Z, Agoussi S, Halama N, Pawlita M, Waterboer T, Eichmüller SB, Jäger D, Eggermont AMM, Zörnig I.

Oncoimmunology. 2018 Feb 12;7(6):e1428157. doi: 10.1080/2162402X.2018.1428157. eCollection 2018.

43.

Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations.

Trabert B, Waterboer T, Idahl A, Brenner N, Brinton LA, Butt J, Coburn SB, Hartge P, Hufnagel K, Inturrisi F, Lissowska J, Mentzer A, Peplonska B, Sherman ME, Wills GS, Woodhall SC, Pawlita M, Wentzensen N.

J Natl Cancer Inst. 2019 Feb 1;111(2):129-136. doi: 10.1093/jnci/djy084.

44.

Immunoprofiling of Chlamydia trachomatis using whole-proteome microarrays generated by on-chip in situ expression.

Hufnagel K, Lueong S, Willhauck-Fleckenstein M, Hotz-Wagenblatt A, Miao B, Bauer A, Michel A, Butt J, Pawlita M, Hoheisel JD, Waterboer T.

Sci Rep. 2018 May 14;8(1):7503. doi: 10.1038/s41598-018-25918-3.

45.

Tobacco smoking and alcohol drinking at diagnosis of head and neck cancer and all-cause mortality: Results from head and neck 5000, a prospective observational cohort of people with head and neck cancer.

Beynon RA, Lang S, Schimansky S, Penfold CM, Waylen A, Thomas SJ, Pawlita M, Waterboer T, Martin RM, May M, Ness AR.

Int J Cancer. 2018 Sep 1;143(5):1114-1127. doi: 10.1002/ijc.31416. Epub 2018 Apr 23.

46.

Are two doses of human papillomavirus vaccine sufficient for girls aged 15-18 years? Results from a cohort study in India.

Bhatla N, Nene BM, Joshi S, Esmy PO, Poli URR, Joshi G, Verma Y, Zomawia E, Pimple S, Prabhu PR, Basu P, Muwonge R, Hingmire S, Sauvaget C, Lucas E, Pawlita M, Gheit T, Jayant K, Malvi SG, Siddiqi M, Michel A, Butt J, Sankaran S, Kannan TPRA, Varghese R, Divate U, Willhauck-Fleckenstein M, Waterboer T, Müller M, Sehr P, Kriplani A, Mishra G, Jadhav R, Thorat R, Tommasino M, Pillai MR, Sankaranarayanan R; Indian HPV vaccine study group.

Papillomavirus Res. 2018 Jun;5:163-171. doi: 10.1016/j.pvr.2018.03.008. Epub 2018 Mar 22.

47.

Serologic markers of viral infection and risk of non-Hodgkin lymphoma: A pooled study of three prospective cohorts in China and Singapore.

Bassig BA, Willhauck-Fleckenstein M, Shu XO, Koh WP, Gao YT, Purdue MP, Xiang YB, Adams-Haduch J, Wang R, Brenner N, Waterboer T, Michel A, Ji BT, Hosgood HD, Rabkin CS, Yang G, Wong JYY, Zhang J, Hu W, Seow WJ, Chow WH, Pawlita M, Zheng W, Yuan JM, Lan Q, Rothman N.

Int J Cancer. 2018 Aug 1;143(3):570-579. doi: 10.1002/ijc.31385. Epub 2018 Apr 6.

48.

Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study.

Sankaranarayanan R, Joshi S, Muwonge R, Esmy PO, Basu P, Prabhu P, Bhatla N, Nene BM, Shaw J, Poli URR, Verma Y, Zomawia E, Pimple S, Tommasino M, Pawlita M, Gheit T, Waterboer T, Sehr P, Pillai MR; Indian HPV vaccine study group.

Vaccine. 2018 Aug 6;36(32 Pt A):4783-4791. doi: 10.1016/j.vaccine.2018.02.087. Epub 2018 Mar 15.

49.

Screening for human papillomavirus-driven oropharyngeal cancer: Considerations for feasibility and strategies for research.

Kreimer AR, Shiels MS, Fakhry C, Johansson M, Pawlita M, Brennan P, Hildesheim A, Waterboer T.

Cancer. 2018 May 1;124(9):1859-1866. doi: 10.1002/cncr.31256. Epub 2018 Mar 2. No abstract available.

50.

Double positivity for HPV-DNA/p16ink4a is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients.

Mena M, Taberna M, Tous S, Marquez S, Clavero O, Quiros B, Lloveras B, Alejo M, Leon X, Quer M, Bagué S, Mesia R, Nogués J, Gomà M, Aguila A, Bonfill T, Blazquez C, Guix M, Hijano R, Torres M, Holzinger D, Pawlita M, Pavon MA, Bravo IG, de Sanjosé S, Bosch FX, Alemany L.

Oral Oncol. 2018 Mar;78:137-144. doi: 10.1016/j.oraloncology.2018.01.010. Epub 2018 Feb 20.

PMID:
29496041

Supplemental Content

Loading ...
Support Center